Novel 3,3′-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis
DARU, Journal of Pharmaceutical Sciences · Published 2026-07-22 · DOI 10.1007/s40199-026-00625-x
Free full text
Authors (7)
Elif Ince-Erguc, Bita Entezari, Hanif Sirinzade, Sibel Suzen, Atilla Akdemir, Oguz Erdogan, Hande Gurer‐Orhan
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Ince-Erguc, E., Entezari, B., Sirinzade, H., et al. (2026). Novel 3,3′-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis. DARU, Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-026-00625-x
Related articles
- The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal
- Tableting of nanoparticle-based formulations for oral delivery: Enhancing biopharmaceutical performance · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Advances in nanostructured drug delivery systems for cardiovascular therapeutics · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal
- Poly (lactic-co-glycolic acid) nanoplatforms for triple-negative breast cancer: current progress, advances, and future outlook · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Eugenol mitigates schizophrenia-like behavioral deficits, oxidative stress, apoptosis, neuroinflammation, and cholinergic dysfunction in ketamine-induced mice · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Plant-derived exosome-like nanovesicles as programmable bio-organic excipients: a next-generation platform for precision and immuno-silent drug delivery · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Deep fused explainable neural architecture for the automatic recognition of therapeutic medicinal plants · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal
- Clinical, humanistic, and economic outcomes of Passiflora alata Curtis use in participants with mild to moderate anxiety: a non-randomized experimental study · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- The paradoxical protective effect of malnutrition in acetaminophen-induced liver injury · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal